Literature DB >> 31401881

Impairment of Bitter Taste Sensor Transient Receptor Potential Channel M5-Mediated Aversion Aggravates High-Salt Intake and Hypertension.

Yuanting Cui1, Hao Wu1, Qiang Li1, Jianwen Liao1, Peng Gao1, Fang Sun1, Hexuan Zhang1, Zongshi Lu1, Xiao Wei1, Chengkang He1, Tianyi Ma1, Xing Wei1, Xiaowei Chen2, Hongting Zheng3, Gangyi Yang4, Daoyan Liu1, Zhiming Zhu1.   

Abstract

Excessive salt consumption leads to cardiovascular diseases. Despite various measures designed to reduce salt intake, daily salt intake remains at a high level. Appropriate salt intake is balanced by salt taste preference triggered by epithelium sodium channel and salt taste aversion evoked by bitter taste sensor, transient receptor potential channel M5 (TRPM5). However, the behavioral mechanism of excessive salt intake remains largely elusive. In this study, wild type and TRPM5-/- mice were applied to study the influence of high-salt administration on epithelium sodium channel/TRPM5 and the associated behavior to salt consumption. We found that long-term high-salt intake impaired the aversive behavior to high-salt stimulation but did not alter the preference to low salt in mice. The mechanistic evidence demonstrated that high-salt intake blunted the TRPM5-mediated aversive behavior to noxious salt stimulation through inhibiting PKC (protein kinase C) activity and PKC-dependent threonine phosphorylation in the tongue epithelium but did not affect the epithelium sodium channel-dependent salt taste preference. Inhibition of TRPM5 also resulted in an impaired aversive response to high salt, with reduced taste perception in bitter cortical field of mice. TRPM5-/- mice showed a lowered aversion to high-salt diet and developed salt-induced hypertension. The impaired perception to bitter taste evoked by high-salt intake also existed in hypertensive patients with high-salt consumption. We demonstrate that long-term high-salt consumption impairs aversive response to concentrated salt by downregulating bitter taste sensor TRPM5. It suggests that enhancing TRPM5 function might antagonize excessive salt intake and high salt-induced hypertension.

Entities:  

Keywords:  hypertension; mice; phosphorylation; protein kinase C; taste

Mesh:

Substances:

Year:  2019        PMID: 31401881     DOI: 10.1161/HYPERTENSIONAHA.119.13358

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  6 in total

1.  Genetic deletion of the Tas2r143/Tas2r135/Tas2r126 cluster reveals that TAS2Rs may not mediate bitter tastant-induced bronchodilation.

Authors:  Ping Lu; Mai K ElMallah; Zeyu Liu; Chan Wu; Jun Chen; Lawrence M Lifshitz; Ronghua ZhuGe
Journal:  J Cell Physiol       Date:  2021-02-08       Impact factor: 6.513

Review 2.  TRPM Channels in Human Diseases.

Authors:  Ivanka Jimenez; Yolanda Prado; Felipe Marchant; Carolina Otero; Felipe Eltit; Claudio Cabello-Verrugio; Oscar Cerda; Felipe Simon
Journal:  Cells       Date:  2020-12-04       Impact factor: 6.600

3.  Mechanisms for the Sour Taste.

Authors:  Jin Zhang; Hojoon Lee; Lindsey J Macpherson
Journal:  Handb Exp Pharmacol       Date:  2022

4.  Nicotine stimulates ion transport via metabotropic β4 subunit containing nicotinic ACh receptors.

Authors:  Praveen Kumar; Petra Scholze; Martin Fronius; Gabriela Krasteva-Christ; Monika I Hollenhorst
Journal:  Br J Pharmacol       Date:  2020-11-09       Impact factor: 8.739

5.  Lack of TRPV1 aggravates obesity-associated hypertension through the disturbance of mitochondrial Ca2+ homeostasis in brown adipose tissue.

Authors:  Li Li; Liqun Ma; Zhidan Luo; Xiao Wei; Yu Zhao; Cui Zhou; Aidi Mou; Zongshi Lu; Mei You; Chengkang He; Huan Ma; Qing Zhou; Lijuan Wang; Tingbing Cao; Yucun Gu; Peng Gao; Zhiming Zhu
Journal:  Hypertens Res       Date:  2022-01-18       Impact factor: 5.528

6.  Correlation among high salt intake, blood pressure variability, and target organ damage in patients with essential hypertension: Study protocol clinical trial (SPIRIT compliant).

Authors:  Wei Cai; MingJian Lang; XiaoBo Jiang; Qian Yu; Congliang Zhou; Wenshu Zou; Xiaohua Zhang; JianGuo Lei
Journal:  Medicine (Baltimore)       Date:  2020-04       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.